Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Quilici

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Cardiology|January 21, 2014
Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndromePierre Deharo, Jacques Quilici, Guillaume Bonnet, et al.
International Journal of Cardiology|August 27, 2014
Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrelPierre Deharo, Mathieu Pankert, Guillaume Bonnet, et al.
Archives of Cardiovascular Diseases|September 28, 2011
Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: the TRASA trialThomas Cuisset, Frederic Franceschi, Sébastien Prevot, et al.
Archives of Cardiovascular Diseases|June 23, 2011
Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical managementThomas Cuisset, Jacques Quilici, Lionel Fugon, et al.
Circulation|September 15, 2004
Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromesJacques Quilici, Nathalie Banzet, Philippe Paule, et al.
International Journal of Cardiology|March 11, 2015
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitorsPierre Deharo, Mathieu Pankert, Jacques Quilici, et al.
American Heart Journal|April 21, 2009
Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stentingThomas Cuisset, Corinne Frere, Jacques Quilici, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 28, 2011
Gender differences in response to cold pressor test assessed with velocity-encoded cardiovascular magnetic resonance of the coronary sinusPierre-Julien Moro, Antonin Flavian, Alexis Jacquier, et al.
The American Journal of Cardiology|August 30, 2011
Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromeThomas Cuisset, Jacques Quilici, Charlotte Grosdidier, et al.
The American Journal of Cardiology|October 6, 2009
Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patientsThomas Cuisset, Corinne Frere, Jacques Quilici, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Cardiology|January 21, 2014
Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndromePierre Deharo, Jacques Quilici, Guillaume Bonnet, et al.
International Journal of Cardiology|August 27, 2014
Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrelPierre Deharo, Mathieu Pankert, Guillaume Bonnet, et al.
Archives of Cardiovascular Diseases|September 28, 2011
Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: the TRASA trialThomas Cuisset, Frederic Franceschi, Sébastien Prevot, et al.
Archives of Cardiovascular Diseases|June 23, 2011
Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical managementThomas Cuisset, Jacques Quilici, Lionel Fugon, et al.
Circulation|September 15, 2004
Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromesJacques Quilici, Nathalie Banzet, Philippe Paule, et al.
International Journal of Cardiology|March 11, 2015
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitorsPierre Deharo, Mathieu Pankert, Jacques Quilici, et al.
American Heart Journal|April 21, 2009
Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stentingThomas Cuisset, Corinne Frere, Jacques Quilici, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 28, 2011
Gender differences in response to cold pressor test assessed with velocity-encoded cardiovascular magnetic resonance of the coronary sinusPierre-Julien Moro, Antonin Flavian, Alexis Jacquier, et al.
The American Journal of Cardiology|August 30, 2011
Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromeThomas Cuisset, Jacques Quilici, Charlotte Grosdidier, et al.
The American Journal of Cardiology|October 6, 2009
Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patientsThomas Cuisset, Corinne Frere, Jacques Quilici, et al.
Pageof 8